Developing novel therapeutic approaches to frailty

Current Pharmaceutical Design

Volumn 15, Issue 29, 2009, Pages 3384-3395

  Morley, John E ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANTINEOPLASTIC AGENT; CILOSTAZOL; CREATINE; CYTOKINE RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONABINOL; ERYTHROPOIETIN; FISH OIL; GROWTH HORMONE; ICOSAPENTAENOIC ACID; IMIDRAPIL; MEGESTROL ACETATE; MYOSTATIN; NANDROLONE; NITRIC OXIDE SYNTHASE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OSTARINE; OXANDROLONE; OXYMETHOLONE; PENTOXIFYLLINE; PERINDOPRIL; PLACEBO; SELECTIVE ANDROGEN RECEPTOR MODULATOR; STAMULUMAB; TESTOSTERONE; UNCLASSIFIED DRUG; VITAMIN D; VITOS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANDROGEN DEFICIENCY; ANEMIA; ANOREXIA; ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CHRONIC FATIGUE SYNDROME; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COUGHING; DEPRESSION; DRUG ACTIVITY; DYNOPENIA; EXERCISE; EXHAUSTION; FATIGUE; FIBROMYALGIA; FRAILTY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERIATRIC DISORDER; HEART FAILURE; HORMONE ACTION; HUMAN; IMMUNOMODULATION; INSULIN RESISTANCE; LUNG NON SMALL CELL CANCER; MITOCHONDRION; MOTOR UNIT; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE STRENGTH; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTAKE; PROTEIN SYNTHESIS; REVIEW; SEX DIFFERENCE; SLEEP APNEA SYNDROME; VENOUS OXYGEN TENSION; WALKING SPEED; WEAKNESS; WEIGHT REDUCTION;

AGED; AGING; ANABOLIC AGENTS; ANEMIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANOREXIA; ATHEROSCLEROSIS; CYTOKINES; EXECUTIVE FUNCTION; FATIGUE; FISH OILS; FRAIL ELDERLY; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA, MUSCLE; MOTOR NEURONS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSTATIN; VITAMIN D;

EID: 70449359214     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789105045     Document Type: Review

References (183)

1. rd, Miller DK. Editorial: something about frailty. J Gerontol A Biol Sci Med Sci 2002; 57: M698-704.
2. Thomas DR, Kamel H, Azharrudin M, Ali AS, Khan A, Javaid U, Morley JE. The relationship of functional status, nutritional assessment, and severity of illness to in-hospital morality. J Nutr Health Aging 2005; 9: 169-175 (Pubitemid 40592329)
3. Narain P, Rubenstein LZ, Wieland GD, Rosbrook B, Strome LS, Pietruszka F, et al. Predictors of immediate and 6-month outcomes in hospitalized elderly patients. The importance of functional status. J Am Geriatr Soc 1988; 36: 775-783 (Pubitemid 18211431)
4. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59: 255-263 (Pubitemid 38375339)
5. Abellan van Kan G, Rolland Y, Bergman H, Morley JE, Kirtchevsky SB, Vellas B. The I.A.N.A. Task Force on Frailty assessment of older people in clinical practice. J Nutr Health Aging 2008; 12: 29-37. (Pubitemid 351156012)
6. Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc 2008; 9: 71-72
7. Ensrud KE, Ewing SK, Cawthon PM, Fink HA, Taylor BC, Cauley JA, et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 2009; 57: 492-498
8. Rockwood K, Abeysundera MJ, Mitnitski A. How should we grade frailty in nursing home patients? J Am Med Dir Assoc 2007; 8: 595-603.
9. Vestergaard S, Nayfield SG, Patel KV, Eldadah B, Cesari M, Ferrucci L, et al. Fatigue in a representative population of older persons and its association with functional impairment, functional limitation, and disability. J Gerontol A Biol Sci Med Sci 2009; 64: 76-82.
10. Heydemann A, McNally E. No more muscle fatigue. J Clin Invest 2009; 119: 448-450
11. Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banazo E, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008; 134: 405-415
12. Chrusch MJ, Chilibeck PD, Chad KE, Davison KS, Burke DG. Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc 2001; 33: 2111-2117 (Pubitemid 33126706)
13. Stout JR, Sue Graves B, Cramer JT, Goldstein ER, Costa PB, Smith AE, et al. Effects of creatine supplementation on the onset of neuromuscular fatigue threshold and muscle strength in elderly men and women (64-86 years). J Nutr Health Aging 2007; 11: 459-464 (Pubitemid 350247015)
14. Tarnopolsky M, Zimmer A, Paikin J, Safdar A, Aboud A, Pearce E, et al. Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS ONE 2007; 2: e991.
15. Chang CT, Wu CH, Yang CW, Huang JY, Wu MS. Creatine monohydrate treatment alleviates muscle cramps associated with haemodialysis. Nephrol Dial Transplant 2002; 17: 1978-1981
16. Greenwood M, Kreider RB, Melton C, Rasmussen C, Lancaster S, Cantler E. Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem 2003; 244: 83-88 (Pubitemid 36411057)
17. rd, Patrick P, Banks WA, Morley JE. Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci 2007; 62: 330-335
18. Bauer JM, Kaiser MJ, Sieber CC. Sarcopenia in nursing home residents. J Am Med Dir Assoc 2008; 9: 545-551
19. Narici MV, Maganaris CN, Reeves ND, Capodaglio P. Effect of aging on human muscle architecture. J Appl Physiol 2003; 95: 2229-2234 (Pubitemid 37444961)
20. rd, Patrick P, Morley PM, Stauber PM et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410-413
21. rd. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Mol Biol 2003; 85: 367-373
22. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR; Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrniol Metab 2001; 86: 724-731
23. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 2999; 107: 123-136
24. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85: 3276-3282
25. Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006; 114: 1829-1837 (Pubitemid 44673358)
26. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997; 96: 526-534 (Pubitemid 27329429)
27. rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661-1667
28. Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, et al. Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab 2009; 94(6): 1991-2001.
29. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J, Bhasin S. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 2008; 56: 1991-1999
30. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc 2006; 54: 1666-1673
31. rd, Kaiser FE, Kraenzle D, Jensen J, Houston K, et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993; 41: 149-152
32. Wittert GA, Chapman IM, Haren MT, MacKintosh S, Coates P, Morley JE. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 2003; 58: 618-625 (Pubitemid 36900168)
33. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005; 90: 1502-1510
34. Srinivas-Shankar U, Wu FC. Frailty and muscle function: role for testosterone? Front Horm Res 2009; 37: 133-149
35. Chapman IM, Visvanathan R, Hammond AJ, Morley JE, Field JB, Tai K, et al. Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. Am J Clin Nutr 2009; 89: 880-889
36. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002; 57: M76-99.
37. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 2006; 91: 3024-3033 (Pubitemid 44271751)
38. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Chalres IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-5216 (Pubitemid 24177823)
39. Frisoli A Jr, Chaves PH, Pinheiro MM, Szejnfeld VL. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. J Gerontol A Biol Sci Med Sci 2005; 60: 648-653
40. McDonald JH, Marcora SM, Jibani MM, Kumwenda MJ, Ahmed W, Lemmey AB. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study. Nephron Clin Pract 2007; 106: c125-35. (Pubitemid 47016331)
41. Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003; 124: 1733-1742 (Pubitemid 37433566)
42. Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, et al. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Med 2006; 7: 146-155 (Pubitemid 43337593)
43. Narayanan R, Mohler ML, Bohl CE, Miller DD, Dalton JT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal 2008; 6: e010.
44. Nair VA, Mustafa SM, Mohler ML, Fisher SJ, Dalton JT, Miller DD. Synthesis of novel iodo derived bicalutamide analogs. Tetrahedron Lett 2004; 45: 9475-9477
45. Morley JE. Should all long-term care residents receive vitamin D? J Am Med Dir Assoc 2007; 8: 69-70.
46. Drinka PJ, Krause PF, Nest LJ, Goodman BM. Determinants of vitamin D levels in nursing home residents. J Am Med Dir Assoc 2007; 8: 76-79 (Pubitemid 46196426)
47. Morley JE, Anker SD, Evans WJ. Cachexia and aging: an update based on the Fourth International Cachexia Meeting. J Nutr Health Aging 2009; 13: 47-55.
48. Hamid Z, Riggs A, Spencer T, Redman C, Bodenner D. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc 2007; 8: 71-75 (Pubitemid 46196421)
49. Munir J, Wright RJ, Carr DB. A quality improvement study on calcium and vitamin D supplementation in long-term care. J Am Med Dir Assoc 2006; 7: 305-309 (Pubitemid 43827464)
50. Drinka PJ. The importance of parathyroid hormone and vitamin D status in the treatment of osteoporosis and renal insufficiency. J Am Med Dir Assoc 2006; 7(3 Suppl): S5-9.
51. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-2264 (Pubitemid 40629192)
52. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999-2006.
53. Kamel HK. Update on osteoporosis management in long-term care: focus on bisphosphonates. J Am Med Dir Assoc 2007; 8: 434-440
54. Wright RM. Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc 2007; 8: 453-457 (Pubitemid 47355300)
55. Shardell M, Hicks GE, Miller RR, Kritchevsky S, Andersen D, Bandinelli S. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009; 64: 69-75.
56. Pramyothin P, Techasurungkul S, Lin J, Wang H, Shah A, Ross PD, et al. Vitamin D status and falls, frailty, and fractures among postmenopausal Japanese women living in Hawaii. Osteoporos Int 2009; Mar 24 [Epub ahead of print].
57. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551-561
58. O'Donnell S, Cranney A, Horsley T, Weiler HA, Atkinson SA, Hanley DA, et al. Efficacy of food fortification on serum 25- hydroxyvitamin D concentrations: systematic review. Am J Clin Nutr 2008; 88: 1528-1534
59. O'Donnell S, Moher D, Thomas K, Hanley DA, Cranney A. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab 2008; 26: 531-542
60. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-1737 (Pubitemid 47403059)
61. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956
62. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008; 29: 407-414
63. Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008; 17: 348-352
64. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-681
65. Kim MJ, Morley JE. The hormonal fountains of youth: myth or reality? J Endocrinol Invest 2005; 28(11 Suppl Proc): 5-14.
66. Chu LW, Lam KS, Tam SC, Hu WJ, Hui SL, Chiu A, et al. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol Metab 2001; 86: 1913-1920 (Pubitemid 32472897)
67. Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby- Whitehead J, Stevens TE, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002; 288: 2282-2292 (Pubitemid 35291758)
68. Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-1 concentrations. Clin Endocrinol 1993; 39: 417-425 (Pubitemid 23308418)
69. Weissberger AJ, Anastasiadis AD, Sturgess I, Martin FC, Smith MA, Sonksen PH. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrionl (Oxf) 2003; 58: 99-107. (Pubitemid 36098855)
70. Hennessey JV, Chromiak JA, DellaVentura S, Reinert SE, Puhl J, Kiel DP, et al. Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 2001; 49: 852-858 (Pubitemid 32743618)
71. Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007; 146: 104-115 (Pubitemid 351640014)
72. Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'Brien F, Svanberg E, and the Serono 9037 Study Team. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2004; 35: 367-375 (Pubitemid 38332797)
73. Chu LW, Lam KS, Tam SC, Hu WJ, Hui SL, Chiu A, et al. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients. J Clin Endocrinol Metab 2001; 86: 1913-1920 (Pubitemid 32472897)
74. Bartke A, Brown-Borg H. Life extension in the dwarf mouse. Curr Top Dev Biol 2004; 63: 189-225.
75. Goldspink G. Research on mechano growth factor: its potential for optimistising physical training as well as misuse in doping. Br J Sports Med 2005; 39: 787-788 (Pubitemid 41564909)
76. Musaro A, Giacinti C, Pelosi L, Dobrowolny G, Barberi L, Nardis C, et al. Stem cell-mediated muscle regeneration and repair in aging and neuromuscular diseases. Eur J Histochem 2007; 51(Suppl 1): 35-43.
77. Hameed M, Toft AD, Pedersen Bk, Harridge SD, Goldspink G. Effects of eccentric cycling exercise on IGF-1 splice variant expression in the muscles of young and elderly people. Scand J Med Sci Sports 2008; 18: 447-452
78. Ukkola O. Ghrelin and metabolic disorders. Curr Protein Pept Sci 2009; 10: 2-7.
79. Gaskin FS, Farr SA, Banks WA, Kumar VB, Morley JE. Ghrelin-induced feeding is dependent on nitric oxide. Peptides 2003; 24: 913-918
80. Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, Miyatake K, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005; 128: 1187-1193 (Pubitemid 41324394)
81. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006; 9: 381-388 (Pubitemid 43290968)
82. Murphy MG, Bach MA, Plotkin D, Bolognese J, Ng J, Krupa D, Cerchio K, Gertz BJ. Oral administration of the growth hormone secretagogue MK-677 increses markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group. J Bone Miner Res 1999; 14: 1181-1188 (Pubitemid 29314062)
83. Bach MA, Rockwood K, Zetterberg C, Thamsborg G, Hebert R, Devogelaer JP, et al., and the MK 0677 Hip Fracture Study Group. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. J Am Geriatr Soc 2004; 52: 516-523
84. Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr., Clasey JC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 2008; 149: 601-611
85. White HK, Petrie CD, Landschulz W, MacLean D, Taylor A, Lyles K, Wei JY, et al. Effects of an Oral Growth Hormone Secretagogue in Older Adults. J Clin Endocrinol Metab 2009; 94: 1198-1206
86. Joulia-Ekaza D, Cabello G. Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp Cell Res 2006; 312: 2401-2414
87. Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 2005; 102: 2519-2524 (Pubitemid 40279409)
88. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 2008; 63: 561-571
89. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361: 1077-1083 (Pubitemid 36369559)
90. Sumukadas D, Witham MD, Struthers AD, McMurdo ME. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ 2007; 177: 867-874 (Pubitemid 47612819)
91. Lynch GS. Update on emerging drugs for sarcopenia - age-related muscle wasting. Expert Opin Emerg Drugs 2008; 13: 655-673
92. Remme WJ. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors: a new dimension in anti-ischaemic therapy?
93. Morley JE, Baumgartner RN. Cytokine-related aging process. J Gerontol A Biol Sci Med Sci 2004; 59: M924-9.
94. Morley JE, Farr SA. Cachexia and neuropeptide Y. Nutrition 2008; 24: 815-819.
95. Roth SM, Metter EJ, Ling S, Ferrucci L. Inflammatory factors in age-related muscle wasting. Curr Opin Rheumatol 2006; 18: 625-630 (Pubitemid 44607418)
96. Elosua R, Bartali B, Ordovas JM, Corsi AM, Lauretani F, Ferrucci L; InCHIANTI Investigators. Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2005; 60: 760-767 (Pubitemid 40881184)
97. Morley JE, Thomas DR. Cachexia: new advances in the management of wasting diseases. J Am Med Dir Assoc 2008; 9: 205-210
98. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006; 83: 735-743
99. Yeh SS, Blackwood K, Schuster MW. The cytokine basis of cachexia and its treatment: are they ready for prime time? J Am Med Dir Assoc 2008; 9: 219-236
100. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-799
101. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, Part II: Laboratory evaluation. Nutrition 2000; 16: 131-140
102. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part I: History, examination, body composition, and screening tools. Nutrition 2000; 16: 50-63.
103. Banks WA, Willoughby LM, Thomas DR, Morley JE. Insulin resistance syndrome in the elderly: assessment of functional, biochemical metabolic, and inflammatory status. Diabetes Care 2007; 30: 2369-2373
104. Mazza AD, Morley JE. Update on diabetes in the elderly and the application of current therapeutics. J Am Med Dir Assoc 2007; 8: 489-492 (Pubitemid 47528138)
105. Mazza AD, Morley JE. Metabolic syndrome and the older male population. Aging Male 2007; 10: 3-8. (Pubitemid 46440590)
106. Haas LB. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities. J Am Med Dir Assoc 2007; 8: 502-510
107. Morley JE. Diabetes and aging: epidemiologic overview. Clin Geriatr Med 2008; 24: 395-405.
108. Rolland Y, Czerwinski S, Abellan van Kan G, Morley JE, Cesari M, Onder G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008; 12: 433-450
109. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activites of daily living disability in the elderly. Obes Res 2004; 12: 1995-2004.
110. Yerdelen D, Koc F, Sarica Y. The effects of gender and age on motor unit number estimation in a normal population. Acta Neurol Belg 2006; 106: 5-8. (Pubitemid 43805087)
111. Roth SM, Schrager MA, Ferrell RE, Reichman SE, Metter EJ, Lynch NA, et al. CNTF genotype is associated with muscular strength and quality in humans across the adult age span. J Appl Physiol 2001; 90: 1205-1210
112. Stephan A, Mateos JM, Kozlov SV, Cinelli P, Kistler AD, Hettwer S, et al. Neurotrypsin cleaves agrin locally at the synapse. FASEB J 2008; 22: 1861-1873 (Pubitemid 351811463)
113. Wolfe RR, Miller SL, Miller KB. Optimal protein intake in the elderly. Clin Nutr 2008; 27: 675-684
114. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009; 12: 86-90.
115. Morley JE. Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci 2003; 58: 131-137
116. Chapman IM, MacIntosh CG, Morley JE, Horowitz M. The anorexia of ageing. Biogerontology 2002; 3: 67-71.
117. Morley JE. Anorexia of aging: physiologic and pathologic. Am J Clin Nutr 1997; 66: 760-773
118. Morley JE. Anorexia, sarcopenia, and aging. Nutrition 2001; 17: 660-663
119. Sloane PD, Ivey J, Helton M, Barrick AL, Cerna A. Nutritional issues in long-term care. J Am Med Dir Assoc 2008; 9: 476-485
120. Jones KL, Doran SM, Hveem K, Bartholomeusz FD, Morley JE, Sun WM, et al. Relation between postprandial satiation and antral area in normal subjects. Am J Clin Nutr 1997; 66: 127-132 (Pubitemid 27278910)
121. Clarkston WK, Pantano MM, Morley JE, Horowitz M, Littlefield JM, Burton FR. Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly vs young adults. Am J Physiol 1997; 272(1 Pt 2): R243-8. (Pubitemid 27068762)
122. MacIntosh CG, Morley JE, Wishart J, Morris H, Jansen JB, Horowitz M, Chapman IM. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 2001; 86: 5830-5837 (Pubitemid 33152631)
123. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci 2001; 56(Spec No 2): 81-88
124. McIntosh CG, Andrews JM, Jones KL, Wishart JM, Morris HA, Jansen JB, et al. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr 1999; 69: 999-1006.
125. rd. Androgen treatment of male hypogonadism in older males. J Steroid Biochem Mol Biol 2003; 85: 367-373
126. rd, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metabolism 2000; 49: 1085-1091
127. rd, Baumgartner RP, Garry PJ. Leptin, adipose tissue and aging - is there a role for testosterone? J Gerontol A Biol Sci Med Sci 1999; 54: B108-9.
128. Baumgartner RN, Waters DL, Morley JE, Patrick P, Montoya GD, Garry PJ. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism 1999; 48: 378-384 (Pubitemid 29116003)
129. Wilson MM, Vaswani S, Liu D, Morley JE, Miller DK. Prevalence and causes of undernutrition in medical outpatients. Am J Med 1998; 104: 56-63. (Pubitemid 28078379)
130. Morley JE, Kraenzle D. Causes of weight loss in a community nursing home. J Am Geriatr Soc 1994; 42: 583-585 (Pubitemid 24180954)
131. Cabrera MA, Mesas AE, Garcia AR, de Andrade SM. Malnutrition and depression among community-dwelling elderly people. J Am Med Dir Assoc 2007; 8: 582-584 (Pubitemid 47605501)
132. Chang JC, Finucane TE, Christmas C, Vaughan W, Schwartz J, Leff B. Nutrition and involuntary weight loss: a pilot study of an educational intervention for nursing home surveyors. J Am Med Dir Assoc 2007; 8: 110-114 (Pubitemid 46196423)
133. Messinger-Rapport BJ, Morley JE, Thomas DR, Gammack JK. Intensive session: New approaches to medical issues in long-term care. J Am Med Dir Assoc 2007; 8: 421-433
134. Bales CW, Buhr G. Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life. J Am Med Dir Assoc 2008; 9: 302-312. (Pubitemid 351737314)
135. Aoyama L, Weintraub N, Reuben DB. Is weight loss in the nursing home a reversible problem? J Am Med Dir Assoc 2006; 7(3 Suppl): S66-72.
136. Berenstein EG, Ortiz Z. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev 2005; 18: CD004310.
137. Evans WJ. Editorial: Megestrol acetate use for weight gain should be carefully considered. J Clin Endocrinol Metab 2007; 92: 420-421
138. Yeh SS, Lovitt S, Schuster MW. Pharmacological treatment of geriatric cachexia: evidence and safety in perspective. J Am Med Dir Assoc 2007; 8: 363-377 (Pubitemid 47019528)
139. Karcic E, Philpot C, Morley JE. Treating malnutrition with megestrol acetate: literature review and review of our experience. J Nutr Health Aging 2002; 6: 191-200. (Pubitemid 34625301)
140. Morley JE. Anorexia in older persons - Epidemiology and optimal treatment. Drugs Aging 1996; 8: 134-155 (Pubitemid 26045083)
141. Anonymous. Megestrol acetate NCD oral suspension - Par Pharmaceutical; megestrol acetate nanocrystal dispersion oral suspension, PAR 100.2. Drugs R D 2007; 8: 403-406
142. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Maillard JA, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002; 20: 567-573 (Pubitemid 34072541)
143. Wilson MM, Philpot C, Morley JE. Anorexia of aging in long term care: is dronabinol an effective appetite stimulant? -A pilot study. J Nutr Health Aging 2007; 11: 195-198 (Pubitemid 46725297)
144. Wilson MM, Thomas DR, Rubenstein LZ, Shibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005; 82: 1074-1081 (Pubitemid 43779767)
145. Puri BK. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol 2007; 60: 122-124
146. Raastad T, Hostmark AT, Stromme SB. Omega-3 fatty acid supplementation does not improve maximal aerobic power, anaerobic threshold and running performance in well-trained soccer players. Scand J Med Sci Sports 1997; 7: 25-31. (Pubitemid 127524002)
147. Peoples GE, McLennan PL, Howe PR, Groeller H. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008; 52: 540-547
148. Petursdottir AL, Farr SA, Morley JE, Banks WA, Skuladottir GV. Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 2008; 63: 1153-1160
149. Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 2009; 81: 319-327
150. Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 2007; 24(1): CD004597. (Pubitemid 351820443)
151. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchiolli R, Barlera S, Franzosi MG, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 2008; 372: 1223-1230
152. Robinson SM, Jameson KA, Batelaan SF, Martin HJ, Syddall HE, Dennison EM, et al. Diet and its relationship with grip strength in community-dwelling older men and women: the Hertfordshire cohort study. J Am Geriatr Soc 2008; 56: 84-90.
153. Rousseau JH, Kleppinger A, Kenny AM. Self-reported dietary intake of Omega-3 fatty acids and association with bone and lower extremity function. J Am Geriatr Soc 2008; Aug 22 [Epub ahead of print]
154. Hiona A, Leeuwenburgh C. The role of mitochondrial DNA mutations in aging and sacopenia: implications for the mitochondrial vicious cycle theory of aging. Exp Gerontol 2008; 43: 24-33. (Pubitemid 350245432)
155. Starr JM, Shiels PG, Harris SE, Pattie A, Pearce MS, Relton CL, Deary IJ. Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79 years from the 1932 Scottish Mental Survey. Mech Ageing Dev 2008; 129: 745-751
156. Semba RD, Ferrucci L, Sun K, Walston J, Varadhan R, Guralnik JM, Fried LP. Oxidative stress and severe walking disability among older women. Am J Med 2007; 120: 1084-1089 (Pubitemid 350176564)
157. Ershler WB. A gripping reality: oxidative stress, inflammation, and the pathway to frailty. J Appl Physiol 2007; 103: 3-5.
158. Chaput JP, Lord C, Cloutier M, Aubertin Leheudre M, Goulet ED, Rousseau S, et al. Relationship between antioxidant intakes and class I sarcopenia in elderly men and women. J Nutr Health Aging 2007; 11: 363-369 (Pubitemid 47121942)
159. Cesari M, Pahor M, Bartali B, Cherubini A, Penninx BW, Williams GR, et al. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr 2004; 79: 289-294 (Pubitemid 41095983)
160. Michelon E, Blaum C, Semba RD, Xue QL, Ricks MO, Fried LP. Vitamin and carotenoid status in older women: associations with the frailty syndrome. J Gerontol A Biol Sci Med Sci 2006; 61: 600-607 (Pubitemid 43912099)
161. Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev 2008; 24(Suppl 1): S52-7. (Pubitemid 351802772)
162. Poon HF, Farr SA, Thongboonkerd V, Lynn BC, Banks WA, Morley JE, et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 2005; 46: 159-168 (Pubitemid 41556623)
163. Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003; 84: 1173-1183 (Pubitemid 36330669)
164. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599-1606 (Pubitemid 33010284)
165. Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2007; (1): CD003748.
166. Morley JE, Haren MT, Rolland Y, Kim MJ. Frailty. Med Clin North Am 2006; 90: 837-847
167. Dharmarajan TS, Avula S, Norkus EP. Anemia increases risk for falls in hospitalized older adults: an evaluation of falls in 362 hospitalized, ambulatory, long-term care, and community patients. J Am Med Dir Assoc 2007; 8(3 Suppl 2): e9-15. (Pubitemid 46359930)
168. Dharmarajan TS. Falls and fractures linked to anemia, delirium, osteomalacia, medications, and more: the path to success is strewn with obstacles. J Am Med Dir Assoc 2007; 8: 549-550
169. Thomas DR. Anemia: it's all about quality of life. J Am Med Dir Assoc 2007; 8: 80-82
170. Chaves PH, Semba RD, Leng SX, Woodman RC, Ferrucci L, Guralnik JM, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 2005; 60: 729-735 (Pubitemid 40881179)
171. Joshi S, Morley JE. Cognitive impairment. Med Clin North Am 2006; 90: 769-787
172. Evans JJ, Greenfield E, Wilson BA, Bateman A. Walking and talking therapy: Improving cognitive-motor dual-tasking in neurological illness. J Int Neuropsychol Soc 2009; 15: 112-120
173. Hausdorff JM, Schweiger A, Herman T, Yogev-Seligmann G, Giladi N. Dual-task decrements in gait: contributing factors among healthy older adults. J Gerontol A Biol Sci Med Sci 2008; 63: 1335-1343
174. rd, Morley JE. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder - a pilot study. Am J Geriatr Psychiatry 2006; 14: 900-910
175. Banks WA, Morley JE. Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol A Biol Sci Med Sci 2003; 58: 314-321
176. Colberg SR, Somma CT, Sechrist SR. Physical activity participation may offset some of the negative impact of diabetes on cognitive function. J Am Med Dir Assoc 2008; 9: 434-438
177. Rolland Y, Abellan van Kan G, Vellas B. Physical activity and Alzheimer's Disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc 2008; 9: 390-405.
178. Morley JE. The magic of exercise. J Am Med Dir Assoc 2008; 9: 375-377
179. Morley JE. Managing persons with dementia in the nursing home: high touch trumps high tech. J Am Med Dir Assoc 2008; 9: 139-146
180. Belgeri M, Morley JE. A step back in time: Is there a place for older drugs in the treatment of dementia? J Gerontol A Biol Sci Med Sci 2004; 59: 1025-1028
181. Abbatecola AM, Paolisso G. Is there a relationship between insulin resistance and frailty syndrome? Curr Pharm Des 2008; 14(4): 405-410
182. Morley JE. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des 2007; 13(35): 3637-3647
183. Trosko JE. Role of diet and nutrition on the alteration of the quality and quantity of stem cells in human aging and the diseases of aging. Curr Pharm Des 2008; 14(26): 2707-2718